2 insiders reported 10 Form 4 transactions for TScan Therapeutics, Inc. (TCRX) over the past 18 months (most recent 2025-12-23). Recent activity: Nichols Weston (Insider) Buy 80,069 shares, Lynx1 Capital Management LP (Insider) Buy 80,069 shares, Nichols Weston (Insider) Buy 75,500 shares, Lynx1 Capital Management LP (Insider) Buy 75,500 shares, Nichols Weston (Insider) Buy 6,232 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-12-23 | Nichols Weston | Insider | Buy | 80,069 | $72,062 |
| 2025-12-23 | Lynx1 Capital Management LP | Insider | Buy | 80,069 | $72,062 |
| 2025-12-23 | Nichols Weston | Insider | Buy | 75,500 | $67,950 |
| 2025-12-23 | Lynx1 Capital Management LP | Insider | Buy | 75,500 | $67,950 |
| 2025-12-23 | Nichols Weston | Insider | Buy | 6,232 | $5,609 |
| 2025-12-23 | Lynx1 Capital Management LP | Insider | Buy | 6,232 | $5,609 |
| 2025-05-21 | Nichols Weston | Insider | Buy | 1.4M | $1.7M |
| 2025-05-21 | Lynx1 Capital Management LP | Insider | Buy | 1.4M | $1.7M |
| 2025-05-21 | Lynx1 Capital Management LP | Insider | Buy | 1.2M | $1.4M |
| 2025-05-21 | Nichols Weston | Insider | Buy | 1.2M | $1.4M |
Source: SEC Form 4 filings · as of 2025-12-23